Biphasic insulin, basal insulin and glucagon-like peptide 1 analogs control blood glucose levels in people with type 2 diabetes, but GLP-1 analogs also encourage weight loss without raising the risk of hypoglycemia, a meta-analysis found. The results were published in Diabetes, Obesity and Metabolism.
GLP-1 analogs are more beneficial for type 2 diabetes
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore